SBIO vs. MHIP
SBIO (ALPS Medical Breakthroughs ETF) and MHIP (Milliman Healthcare Inflation Plus ETF) are both Health & Biotech Equities funds. SBIO is passively managed, while MHIP is actively managed. A 0.50 correlation means they provide meaningful diversification when combined. SBIO charges 0.50%/yr vs 0.55%/yr for MHIP.
Performance
SBIO vs. MHIP - Performance Comparison
Loading charts...
Returns By Period
SBIO
- 1D
- -0.07%
- 1M
- 23.75%
- 6M
- 28.37%
- YTD
- 27.47%
- 1Y
- 97.37%
- 3Y*
- 28.19%
- 5Y*
- 8.12%
- 10Y*
- 11.56%
MHIP
- 1D
- -0.52%
- 1M
- 1.00%
- 6M
- —
- YTD
- —
- 1Y
- —
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
SBIO vs. MHIP - Yearly Performance Comparison
| 2026 (YTD) | |
|---|---|
SBIO ALPS Medical Breakthroughs ETF | 15.03% |
MHIP Milliman Healthcare Inflation Plus ETF | -0.39% |
Correlation
The correlation between SBIO and MHIP is 0.50, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.
| Correlation | |
|---|---|
Correlation (All Time) Calculated using the full available price history since Apr 21, 2026 | 0.50 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
SBIO vs. MHIP — Risk / Return Rank
SBIO
MHIP
Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.
SBIO vs. MHIP - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for ALPS Medical Breakthroughs ETF (SBIO) and Milliman Healthcare Inflation Plus ETF (MHIP). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| SBIO | MHIP | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | — | — | |
| Sortino ratioReturn per unit of downside risk | — | — | |
| Omega ratioGain probability vs. loss probability | 1.48 | — | — |
| Calmar ratioReturn relative to maximum drawdown | 7.74 | — | — |
| Martin ratioReturn relative to average drawdown | 21.48 | — | — |
Loading charts...
Drawdowns
SBIO vs. MHIP - Drawdown Comparison
The maximum SBIO drawdown since its inception was -63.06%, which is greater than MHIP's maximum drawdown of -3.09%. Use the drawdown chart below to compare losses from any high point for SBIO and MHIP.
Loading charts...
Drawdown Indicators
| SBIO | MHIP | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -63.06% | -3.09% | -59.97% |
Max Drawdown (1Y)Largest decline over 1 year | -12.66% | — | — |
Max Drawdown (3Y)Largest decline over 3 years | -42.44% | — | — |
Max Drawdown (5Y)Largest decline over 5 years | -52.49% | — | — |
Max Drawdown (10Y)Largest decline over 10 years | -63.06% | — | — |
Current DrawdownCurrent decline from peak | -5.29% | -1.99% | -3.30% |
Average DrawdownAverage peak-to-trough decline | -28.23% | -1.27% | -26.96% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 4.55% | — | — |
Volatility
SBIO vs. MHIP - Volatility Comparison
Loading charts...
Volatility by Period
| SBIO | MHIP | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 9.91% | — | — |
Volatility (6M)Calculated over the trailing 6-month period | 23.91% | — | — |
Volatility (1Y)Calculated over the trailing 1-year period | 30.59% | 11.68% | +18.91% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 33.85% | 11.68% | +22.17% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 33.15% | 11.68% | +21.47% |
SBIO vs. MHIP - Expense Ratio Comparison
SBIO has a 0.50% expense ratio, which is lower than MHIP's 0.55% expense ratio.
Dividends
SBIO vs. MHIP - Dividend Comparison
Neither SBIO nor MHIP has paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
MHIP Milliman Healthcare Inflation Plus ETF | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
SBIO ALPS Medical Breakthroughs ETF | 0.00% | 0.00% | 3.55% | 0.22% | 0.00% | 0.00% | 0.00% | 0.04% | 2.79% | 1.77% |
Frequently Asked Questions
SBIO and MHIP have a correlation of 0.50, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
On fees, SBIO is cheaper at 0.50% per year. The better choice depends on whether you care most about return, fees, risk, or income.
SBIO is cheaper with a 0.50% expense ratio, compared with 0.55% for MHIP.
SBIO and MHIP have nearly identical dividend yields, around 0.00%.
They also come from different issuers: SS&C and Milliman. Their fees differ too: 0.50% for SBIO and 0.55% for MHIP.
Find the right allocation for SBIO and MHIP
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer